| LB |
LandBridge Co LLC |
Class A Shares |
17.2% |
$239M |
$41.7M |
4.01M |
+21.1% |
Morgan Stanley |
30 Jun 2025 |
| MCR |
MFS CHARTER INCOME TRUST |
Common Stock |
15.9% |
$42.5M |
|
6.68M |
|
Morgan Stanley |
30 Jun 2025 |
| WEA |
WESTERN ASSET PREMIER BOND FUND |
Common Shares of Beneficial Interest |
15.6% |
$20M |
$1.65M |
1.86M |
+8.96% |
Morgan Stanley |
30 Jun 2025 |
| KTCC |
KEY TRONIC CORP |
Common Stock |
14.8% |
$5.62M |
-$472K |
1.59M |
-7.74% |
Morgan Stanley |
30 Sep 2025 |
| FPF |
First Trust Intermediate Duration Preferred & Income Fund |
Common Stock |
13% |
$151M |
|
7.89M |
|
Morgan Stanley |
30 Sep 2025 |
| BMN |
BlackRock 2037 Municipal Target Term Trust |
Common Shares of Beneficial Interest |
13% |
$19.1M |
$1.72M |
799K |
+9.89% |
Morgan Stanley |
31 Mar 2025 |
| XOMA |
XOMA Royalty Corp |
Common Stock |
12.7% |
$37.1M |
$10.1M |
1.53M |
+37.3% |
Morgan Stanley |
30 May 2025 |
| AGL |
agilon health, inc. |
Common Stock |
12.2% |
$193M |
|
50.2M |
|
Morgan Stanley |
31 Mar 2025 |
| OPPPRB |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
4.75% Series B Cumulative Preferred Shares |
11.9% |
$5.46M |
-$1.35M |
285K |
-19.8% |
Morgan Stanley |
30 Sep 2025 |
| ABUS |
Arbutus Biopharma Corp |
Common Shares |
11.4% |
$70.8M |
|
21.5M |
|
Morgan Stanley |
31 Dec 2024 |
| GBAB |
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust |
Common Shares of Beneficial Interest |
10.4% |
$42.7M |
$6.34M |
2.8M |
+17.4% |
Morgan Stanley |
31 Jul 2025 |
| BWG |
BrandywineGLOBAL-Global Income Opportunities Fund Inc |
Common Stock |
10.3% |
$15M |
-$1.59M |
1.73M |
-9.56% |
Morgan Stanley |
30 Sep 2025 |
| AUR |
Aurora Innovation, Inc. |
Class A Common Stock |
10.1% |
$1.03B |
$129M |
141M |
+14.3% |
Morgan Stanley |
31 Mar 2025 |
| EMD |
WESTERN ASSET EMERGING MARKETS DEBT FUND INC. |
Common Stock |
9.7% |
$58.2M |
$26.2M |
5.64M |
+81.7% |
Morgan Stanley |
30 Sep 2025 |
| AOD |
abrdn Total Dynamic Dividend Fund |
Common Stock |
9.5% |
$81.6M |
|
10M |
|
Morgan Stanley |
31 Mar 2025 |
| RPRX |
Royalty Pharma plc |
Class A Ordinary Shares |
9.2% |
$1.39B |
|
38.9M |
|
Morgan Stanley |
30 Jun 2025 |
| BLKB |
BLACKBAUD INC |
Common Stock |
9.2% |
$288M |
|
4.51M |
|
Morgan Stanley |
31 Mar 2025 |
| NPCT |
NUVEEN CORE PLUS IMPACT FUND |
Common Shares of Beneficial Interest |
9% |
$26.5M |
$4.91M |
2.59M |
+22.7% |
Morgan Stanley |
31 Mar 2025 |
| OPP |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
Common Stock |
8.7% |
$16.4M |
|
2M |
|
Morgan Stanley |
31 Dec 2024 |
| BBNX |
Beta Bionics, Inc. |
Common Stock |
8.6% |
$74.3M |
$16.1M |
3.74M |
+27.7% |
Morgan Stanley |
30 Sep 2025 |
| BGY |
BlackRock Enhanced International Dividend Trust |
Common Stock |
8.6% |
$45.7M |
|
8.24M |
|
Morgan Stanley |
31 Dec 2024 |
| WIW |
WESTERN ASSET INFLATION-LINKED OPPORTUNITIES & INCOME FUND |
Common Shares of Beneficial Interest |
8.5% |
$45.9M |
$6.01M |
5.22M |
+15% |
Morgan Stanley |
30 Jun 2025 |
| FFA |
FIRST TRUST ENHANCED EQUITY INCOME FUND |
Common Stock |
8.5% |
$34.8M |
|
1.7M |
|
Morgan Stanley |
30 Jun 2025 |
| LUNG |
Pulmonx Corp |
Common Stock |
8.5% |
$17.5M |
$2.2M |
3.39M |
+14.4% |
Morgan Stanley |
31 Mar 2025 |
| GROV |
Grove Collaborative Holdings, Inc. |
Class A Common Stock |
8.5% |
$5.05M |
$632K |
3.41M |
+14.3% |
Morgan Stanley |
30 Jun 2025 |
| KVYO |
Klaviyo, Inc. |
Series A Common Stock |
8.4% |
$286M |
|
10.3M |
|
Morgan Stanley |
30 Sep 2025 |
| GUG |
Guggenheim Active Allocation Fund |
Common Shares |
8.4% |
$43.3M |
$5.74M |
2.78M |
+15.3% |
Morgan Stanley |
30 Sep 2025 |
| NXDTPRA |
NEXPOINT DIVERSIFIED REAL ESTATE TRUST |
5.50% Series A Cumulative Preferred Shares |
8.4% |
$4.02M |
$1.11M |
284K |
+38.2% |
Morgan Stanley |
30 Sep 2025 |
| ASA |
ASA Gold & Precious Metals Ltd |
Common Shares |
8.3% |
$71.7M |
$16.9M |
1.57M |
+30.8% |
Morgan Stanley |
30 Sep 2025 |
| EMO |
ClearBridge Energy Midstream Opportunity Fund Inc. |
Common Stock |
8.3% |
$69M |
$16.2M |
1.54M |
+30.7% |
Morgan Stanley |
30 Sep 2025 |
| NPCE |
NeuroPace Inc |
Common Stock |
8.3% |
$28.9M |
|
2.49M |
|
Morgan Stanley |
31 Dec 2024 |
| RIV |
RIVERNORTH OPPORTUNITIES FUND, INC. |
Common Stock |
8.2% |
$20.4M |
|
1.77M |
|
Morgan Stanley |
31 Mar 2025 |
| AFRM |
Affirm Holdings, Inc. |
Class A Common Stock |
8.1% |
$1.09B |
|
22.1M |
|
Morgan Stanley |
31 Dec 2024 |
| TERN |
Terns Pharmaceuticals, Inc. |
Common Stock |
8.1% |
$20.7M |
|
7.1M |
|
Morgan Stanley |
31 Mar 2025 |
| GOOS |
Canada Goose Holdings Inc. |
Subordinate Voting Shares |
7.9% |
$50M |
|
3.62M |
|
Morgan Stanley |
30 Sep 2025 |
| GLQ |
Clough Global Equity Fund |
Common Stock |
7.9% |
$9.12M |
|
1.48M |
|
Morgan Stanley |
31 Dec 2024 |
| APLS |
Apellis Pharmaceuticals, Inc. |
Common Stock |
7.7% |
$172M |
|
9.59M |
|
Morgan Stanley |
31 Dec 2024 |
| NFJ |
Virtus Dividend, Interest & Premium Strategy Fund |
Common Shares of Beneficial Interest |
7.7% |
$84.3M |
|
7.33M |
|
Morgan Stanley |
31 Mar 2025 |
| DOYU |
DouYu International Holdings Ltd |
Ordinary Shares / American Depositary Shares |
7.2% |
$16.4M |
|
2.18M |
|
Morgan Stanley |
30 Sep 2025 |
| IONQ |
IonQ, Inc. |
Common Stock |
7.1% |
$779M |
|
18.6M |
|
Morgan Stanley |
30 Jun 2025 |
| CACI |
CACI INTERNATIONAL INC /DE/ |
Common Stock |
7.1% |
$774M |
-$132M |
1.55M |
-14.6% |
Morgan Stanley |
30 Sep 2025 |
| WEX |
WEX Inc. |
Common Stock |
7.1% |
$315M |
|
2.42M |
|
Morgan Stanley |
31 Mar 2025 |
| MUE |
BLACKROCK MUNIHOLDINGS QUALITY FUND II, INC. |
Common Shares |
7.1% |
$15M |
|
1.56M |
|
Morgan Stanley |
31 Dec 2024 |
| AMG |
AFFILIATED MANAGERS GROUP, INC. |
Common Stock |
7% |
$473M |
|
1.98M |
|
Morgan Stanley |
30 Sep 2025 |
| EVH |
Evolent Health, Inc. |
Class A Common Stock |
7% |
$91.8M |
|
8.21M |
|
Morgan Stanley |
30 Jun 2025 |
| ODD |
Oddity Tech Ltd |
Class A Ordinary Shares |
6.9% |
$197M |
$46.4M |
3.16M |
+30.8% |
Morgan Stanley |
30 Sep 2025 |
| GAXY |
GALAXY NEXT GENERATION, INC. |
Common Stock |
6.9% |
$48.4K |
|
4.84M |
|
Morgan Stanley |
31 Dec 2024 |
| TSHA |
Taysha Gene Therapies, Inc. |
Common Stock |
6.7% |
$44.5M |
-$2.03M |
16.9M |
-4.37% |
Morgan Stanley |
30 Jun 2025 |
| CEVA |
CEVA INC |
Common Stock |
6.7% |
$36.8M |
|
1.61M |
|
Morgan Stanley |
30 Jun 2025 |
| CCCC |
C4 Therapeutics, Inc. |
Common Stock |
6.7% |
$7.03M |
$1.36M |
4.75M |
+24.1% |
Morgan Stanley |
30 Jun 2025 |
| NBB |
Nuveen Taxable Municipal Income Fund |
Common Shares of Beneficial Interest |
6.6% |
$30.5M |
|
1.94M |
|
Morgan Stanley |
30 Jun 2025 |
| LSAK |
LESAKA TECHNOLOGIES INC |
Common Stock |
6.6% |
$24.9M |
|
5.21M |
|
Morgan Stanley |
31 Dec 2024 |
| NET |
Cloudflare, Inc. |
Class A Common Stock |
6.5% |
$2.44B |
|
20.2M |
|
Morgan Stanley |
31 Mar 2025 |
| CNM |
Core & Main, Inc. |
Class A Common Stock |
6.5% |
$671M |
-$147M |
12.5M |
-18% |
Morgan Stanley |
30 Sep 2025 |
| STOK |
Stoke Therapeutics, Inc. |
Common Stock |
6.5% |
$32.6M |
|
3.43M |
|
Morgan Stanley |
31 Dec 2024 |
| NPFD |
Nuveen Variable Rate Preferred & Income Fund |
Common Shares of Beneficial Interest |
6.5% |
$30.4M |
$18.9M |
1.57M |
+164% |
Morgan Stanley |
30 Jun 2025 |
| RGT |
ROYCE GLOBAL TRUST, INC. |
Common Stock |
6.5% |
$5.25M |
|
425K |
|
Morgan Stanley |
30 Jun 2025 |
| CSL |
CARLISLE COMPANIES INC |
Common Stock |
6.4% |
$1.15B |
|
2.78M |
|
Morgan Stanley |
30 Jun 2025 |
| NSIT |
INSIGHT ENTERPRISES INC |
Common Stock |
6.4% |
$229M |
$43.5M |
2.02M |
+23.5% |
Morgan Stanley |
30 Sep 2025 |
| PCOR |
PROCORE TECHNOLOGIES, INC. |
Common Stock |
6.3% |
$692M |
|
9.49M |
|
Morgan Stanley |
30 Sep 2025 |
| ARMK |
Aramark |
Common Stock |
6.3% |
$554M |
|
16.8M |
|
Morgan Stanley |
31 Mar 2025 |
| CRTO |
Criteo S.A. |
American Depository Shares / Ordinary Shares |
6.3% |
$79.9M |
|
3.34M |
|
Morgan Stanley |
30 Jun 2025 |
| ANAB |
ANAPTYSBIO, INC |
Common Stock |
6.3% |
$48.1M |
|
1.85M |
|
Morgan Stanley |
30 Jun 2025 |
| HFRO |
HIGHLAND OPPORTUNITIES & INCOME FUND |
Common Shares of Beneficial Interest |
6.3% |
$18.2M |
$546K |
3.48M |
+3.09% |
Morgan Stanley |
30 Jun 2025 |
| FTF |
FRANKLIN LTD DURATION INCOME TRUST |
Common Shares of Beneficial Interest |
6.3% |
$16M |
|
2.55M |
|
Morgan Stanley |
31 Mar 2025 |
| PSF |
Cohen & Steers Select Preferred & Income Fund, Inc. |
Common Stock |
6.3% |
$14.7M |
|
762K |
|
Morgan Stanley |
31 Mar 2025 |
| QXO |
QXO, Inc. |
Common Stock |
6.2% |
$880M |
|
41.6M |
|
Morgan Stanley |
30 Jun 2025 |
| COLM |
COLUMBIA SPORTSWEAR CO |
Common Stock |
6.2% |
$178M |
|
3.4M |
|
Morgan Stanley |
30 Sep 2025 |
| KRNT |
Kornit Digital Ltd. |
Ordinary Shares |
6.2% |
$52.1M |
-$14.1M |
2.8M |
-21.3% |
Morgan Stanley |
31 Mar 2025 |
| NVST |
Envista Holdings Corp |
Common Stock |
6.1% |
$206M |
-$81.7M |
10.1M |
-28.4% |
Morgan Stanley |
30 Sep 2025 |
| TYG |
TORTOISE ENERGY INFRASTRUCTURE CORP |
Common Stock |
6.1% |
$45.4M |
$3.66M |
1.05M |
+8.78% |
Morgan Stanley |
30 Jun 2025 |
| NML |
Neuberger Berman Energy Infrastructure & Income Fund Inc. |
Common Stock |
6.1% |
$30.5M |
|
3.46M |
|
Morgan Stanley |
30 Jun 2025 |
| PLRX |
PLIANT THERAPEUTICS, INC |
Common Stock |
6.1% |
$5.27M |
|
3.74M |
|
Morgan Stanley |
30 Jun 2025 |
| KEX |
KIRBY CORP |
Common Stock |
6% |
$327M |
|
3.39M |
|
Morgan Stanley |
31 Mar 2025 |
| SPHR |
Sphere Entertainment Co. |
Class A Common Stock |
6% |
$109M |
$29.6M |
1.75M |
+37.5% |
Morgan Stanley |
30 Sep 2025 |
| RMT |
ROYCE MICRO-CAP TRUST, INC. |
Common Stock |
6% |
$25.3M |
|
3.09M |
|
Morgan Stanley |
31 Mar 2025 |
| BRCB |
Black Rock Coffee Bar, Inc. |
Class A Common Stock |
6% |
$21.9M |
|
919K |
|
Morgan Stanley |
30 Sep 2025 |
| USPH |
U S PHYSICAL THERAPY INC /NV |
Common Stock |
5.9% |
$60M |
|
890K |
|
Morgan Stanley |
31 Dec 2024 |
| OPPPRA |
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. |
4.375% Series A Cumulative Perpetual Preferred Stock |
5.9% |
$2.43M |
-$487K |
142K |
-16.7% |
Morgan Stanley |
30 Sep 2025 |
| ZYME |
ZYMEWORKS INC |
Common Stock |
5.8% |
$51M |
|
4.06M |
|
Morgan Stanley |
31 Mar 2025 |
| SMLR |
Semler Scientific, Inc. |
Common Stock |
5.8% |
$36M |
|
791K |
|
Morgan Stanley |
30 Jun 2025 |
| TE |
T1 Energy Inc. |
Common Stock |
5.8% |
$22.5M |
|
10.3M |
|
Morgan Stanley |
30 Sep 2025 |
| HIO |
WESTERN ASSET HIGH INCOME OPPORTUNITY FUND INC. |
Common Shares of Beneficial Interest |
5.8% |
$20.7M |
|
5.48M |
|
Morgan Stanley |
31 Dec 2024 |
| FDS |
FACTSET RESEARCH SYSTEMS INC |
Common Stock |
5.7% |
$967M |
|
2.17M |
|
Morgan Stanley |
30 Jun 2025 |
| LSTR |
LANDSTAR SYSTEM INC |
Common Stock |
5.7% |
$242M |
|
1.97M |
|
Morgan Stanley |
30 Sep 2025 |
| ASGI |
abrdn Global Infrastructure Income Fund |
Common Shares of Beneficial Interest |
5.7% |
$30.5M |
$6.23M |
1.64M |
+25.7% |
Morgan Stanley |
31 Mar 2025 |
| LNTH |
Lantheus Holdings, Inc. |
Common Stock |
5.6% |
$194M |
|
3.78M |
|
Morgan Stanley |
30 Sep 2025 |
| FUN |
Six Flags Entertainment Corporation/NEW |
Common Stock |
5.6% |
$129M |
|
5.7M |
|
Morgan Stanley |
30 Sep 2025 |
| TBBB |
BBB FOODS INC |
Class A Common Shares |
5.6% |
$65.4M |
|
2.18M |
|
Morgan Stanley |
31 Dec 2024 |
| SLQT |
SelectQuote, Inc. |
Common Stock |
5.6% |
$24.3M |
|
10.1M |
|
Morgan Stanley |
30 Jun 2025 |
| GLO |
Clough Global Opportunities Fund |
Common Shares of Beneficial Interest |
5.6% |
$11.3M |
|
2.41M |
|
Morgan Stanley |
31 Dec 2024 |
| RERE |
ATRenew Inc. |
Class A Ordinary Shares |
5.6% |
$9.78M |
|
4.89M |
|
Morgan Stanley |
31 Dec 2024 |
| TRMB |
TRIMBLE INC |
Common Stock |
5.5% |
$1.04B |
|
13.1M |
|
Morgan Stanley |
30 Jun 2025 |
| ROIV |
Roivant Sciences Ltd. |
Common Shares |
5.5% |
$409M |
|
37.6M |
|
Morgan Stanley |
30 Jun 2025 |
| ARRY |
Array Technologies, Inc. |
Common Stock |
5.4% |
$67.1M |
|
8.24M |
|
Morgan Stanley |
30 Sep 2025 |
| TPB |
Turning Point Brands, Inc |
Common Stock |
5.4% |
$56.3M |
|
952K |
|
Morgan Stanley |
31 Dec 2024 |
| NBXG |
Neuberger Berman Next Generation Connectivity Fund Inc. |
Shares of Common Stock |
5.4% |
$51.1M |
|
4.25M |
|
Morgan Stanley |
31 Mar 2025 |
| URGN |
UroGen Pharma Ltd. |
Ordinary Shares |
5.4% |
$35.4M |
$24.7M |
2.49M |
+231% |
Morgan Stanley |
30 Jun 2025 |
| MAPS |
WM TECHNOLOGY, INC. |
Class A Common Stock |
5.4% |
$6.38M |
|
5.65M |
|
Morgan Stanley |
31 Mar 2025 |
| NCZPRA |
Virtus Convertible & Income Fund II |
5.50% Series A Cumulative Preferred Shares |
5.4% |
$4.86M |
-$1.43M |
234K |
-22.8% |
Morgan Stanley |
30 Sep 2025 |